NSD1 and sarcoma: For instance, sarcomas harbor high-frequency H3.3G34R and H3.3K36M mutations that directly prevent the binding of H3K36me2/3 writer NSD1/2, thus reducing PRC2-H3K36me2 interaction and increasing H3K27me3 levels (Lu et al., 2016).